• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胚胎组织和细胞培养中细胞侵袭性的检测。

The testing of cell invasiveness in embryonic tissue and in cell culture.

作者信息

Ikić D, Beck M, Turner V

出版信息

Dev Biol Stand. 1976;37:235-40.

PMID:1036400
Abstract

The subcutis of 11-day-old chick embryos, 15- to 18-day-old mouse embryos and the skin muscle tissue of human fetus were stretched on lens paper in a Petri dish and seeded with a piece of LED-Widr or HDC cell sheet. Mem + 10% FCS was added. After three days incubation the material was fixed, sectioned and H-E stained. In the second part of our investigation several cell lines were prepared on cover slips. When confluent, the cultures were inoculated with 1-2 drops of cell suspension of another cell line. Three days after the seeding of cell suspension on the confluent cell sheet the cultures were fixed and stained. It can be seen in the organ cultures that LED-Widr cells closely adhere to the embryonic tissue which in some places they are invading. In tissue culture examination we found that heteroploid cells seeded on a confluent sheet of diploid cells adhered but that a diploid cell seeded on epithelial-like heteroploid cells would not adhere. The testing of invasiveness in embryonic tissue in organ culture showed that it can be a useful model. By seeding suspended cells of fibroblast lines on a confluent sheet of heteroploid cell lines their contact inhibition or their invasive ability can be determined. The seeding of heteroploid cell lines on diploid cell lines can be used as a model for the study of the mechanism of invasion into normal tissue and for the in vitro study of invasion inhibiting properties of certain substances.

摘要

将11日龄鸡胚的皮下组织、15至18日龄小鼠胚胎的皮下组织以及人胎儿的皮肤肌肉组织铺展在培养皿中的镜头纸上,接种一片LED-Widr或HDC细胞片。加入含10%胎牛血清的培养基。孵育三天后,将材料固定、切片并进行苏木精-伊红染色。在我们研究的第二部分,在盖玻片上制备了几种细胞系。当细胞汇合时,用另一种细胞系的1-2滴细胞悬液接种培养物。在汇合细胞片上接种细胞悬液三天后,将培养物固定并染色。在器官培养中可以看到,LED-Widr细胞紧密附着于胚胎组织,在某些地方它们还侵入了胚胎组织。在组织培养检查中,我们发现接种在汇合二倍体细胞片上的异倍体细胞会附着,但接种在上皮样异倍体细胞上的二倍体细胞不会附着。在器官培养中对胚胎组织侵袭性的测试表明,它可以是一个有用的模型。通过将成纤维细胞系的悬浮细胞接种在汇合的异倍体细胞系片上,可以确定它们的接触抑制或侵袭能力。将异倍体细胞系接种在二倍体细胞系上可作为研究侵入正常组织机制以及某些物质体外侵袭抑制特性的模型。

相似文献

1
The testing of cell invasiveness in embryonic tissue and in cell culture.胚胎组织和细胞培养中细胞侵袭性的检测。
Dev Biol Stand. 1976;37:235-40.
2
Invasion of rat neurogenic cell lines in embryonic chick heart fragments in vitro.
J Natl Cancer Inst. 1981 Apr;66(4):723-8.
3
Culture of bovine oviduct epithelial cells (BOEC).牛输卵管上皮细胞(BOEC)的培养。
Anat Rec. 1995 Nov;243(3):347-56. doi: 10.1002/ar.1092430309.
4
High-density seeding of myocyte cells for cardiac tissue engineering.用于心脏组织工程的心肌细胞高密度接种
Biotechnol Bioeng. 2003 May 20;82(4):403-14. doi: 10.1002/bit.10594.
5
An in vitro model for cancer invasion: 1. Grading and quantitation of aggressiveness.
Anticancer Res. 1987 Nov-Dec;7(6):1133-41.
6
An experimental model for ovarian tumor invasion of cultured mesothelial cell monolayer.培养的间皮细胞单层卵巢肿瘤侵袭的实验模型
Lab Invest. 1994 Mar;70(3):333-8.
7
Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.小鼠滋养层细胞系:II——侵袭潜能与蛋白酶之间的关系。
In Vivo. 1998 Mar-Apr;12(2):209-17.
8
Adhesion of malignant and nonmalignant cells to cultured embryonic substrates.恶性和非恶性细胞与培养的胚胎基质的黏附。
Cancer Res. 1975 Nov;35(11 Pt 1):3164-71.
9
Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.角膜内皮细胞有丝分裂抑制机制:接触抑制和转化生长因子-β2
Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2152-9.
10
["Stationary phase aging" of cell culture: an attempt of evaluation of growth medium "age" effect].细胞培养的“静止期老化”:评估生长培养基“老化”效应的尝试
Tsitologiia. 2005;47(4):318-22.

引用本文的文献

1
Human muscle: a model for the study of human neoplasia.
Invest New Drugs. 1983;1(4):297-302. doi: 10.1007/BF00177412.